2019 - Albany Medical Center Prize in Medicine and Biomedical Research
2019 - Distinguished Fellows of the American Association of Immunologists (AAI)
2017 - Karl Landsteiner Memorial Award, American Association of Blood Banks (AABB)
2008 - Robert Koch Prize
2004 - Jessie Stevenson Kovalenko Medal, US National Academy of Sciences For his seminal studies that defined the physical properties, purification, and growth regulation of multipotent hematopoietic stem cells.
2003 - J. Allyn Taylor International Prize in Medicine, Robarts Research Institute
2002 - Member of the National Academy of Medicine (NAM)
1990 - Fellow of the American Academy of Arts and Sciences
1990 - Fellow of the American Association for the Advancement of Science (AAAS)
1989 - Member of the National Academy of Sciences
1988 - Robert J. and Claire Pasarow Foundation Medical Research Award
Irving L. Weissman mainly focuses on Stem cell, Immunology, Haematopoiesis, Cell biology and Progenitor cell. His Stem cell research is multidisciplinary, relying on both Molecular biology, Cellular differentiation, Adult stem cell and Bone marrow. His Molecular biology study combines topics in areas such as T cell, Gene, Cell adhesion molecule and B cell.
His biological study spans a wide range of topics, including Cancer and Cancer research. As a part of the same scientific study, Irving L. Weissman usually deals with the Haematopoiesis, concentrating on Myeloid and frequently concerns with Dendritic cell homeostasis and Lymphopoiesis. His research in Cell biology intersects with topics in Telomere, Embryonic stem cell and Genetics.
Stem cell, Immunology, Cell biology, Haematopoiesis and Progenitor cell are his primary areas of study. His Stem cell research incorporates themes from Cancer research, Cellular differentiation, Adult stem cell, Bone marrow and Transplantation. Irving L. Weissman combines topics linked to Cytotoxic T cell with his work on Immunology.
Irving L. Weissman interconnects Endothelial stem cell, Embryonic stem cell, Induced pluripotent stem cell and Cell in the investigation of issues within Cell biology. The various areas that Irving L. Weissman examines in his Haematopoiesis study include Myeloid, Molecular biology, Hematopoietic stem cell transplantation and Myeloid leukemia. His Molecular biology research is multidisciplinary, incorporating elements of T cell, Gene and B cell.
Irving L. Weissman focuses on Cell biology, Cancer research, CD47, Immunology and Stem cell. Irving L. Weissman studies Progenitor cell, a branch of Cell biology. Irving L. Weissman combines subjects such as Stromal cell, Pathology and Cellular differentiation with his study of Progenitor cell.
His Cancer research research is multidisciplinary, relying on both Cancer cell, Cancer, Metastasis, Cancer stem cell and Cancer immunotherapy. Irving L. Weissman is studying Haematopoiesis, which is a component of Stem cell. His Haematopoiesis research incorporates elements of Myeloid and Bone marrow.
The scientist’s investigation covers issues in Cell biology, Immunology, CD47, Cancer research and Stem cell. Irving L. Weissman mostly deals with Progenitor cell in his studies of Cell biology. His studies in Progenitor cell integrate themes in fields like Cell cycle, Cartilage, Cellular differentiation and Regeneration.
The concepts of his Immunology study are interwoven with issues in Haematopoiesis, Hematopoietic stem cell and Transplantation. His Cancer research research is multidisciplinary, incorporating perspectives in Lung cancer, Phagocytosis and Transgene. His Stem cell study focuses on Stem cell theory of aging in particular.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Stem cells, cancer, and cancer stem cells
Tannishtha Reya;Tannishtha Reya;Sean J. Morrison;Michael F. Clarke;Irving L. Weissman.
Nature (2001)
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
Jun Liu;Jesse D. Farmer;Willam S. Lane;Jeff Friedman.
Cell (1991)
Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.
Michael F. Clarke;John E. Dick;Peter B. Dirks;Connie J. Eaves.
Cancer Research (2006)
Purification and Characterization of Mouse Hematopoietic Stem Cells
Gerald J. Spangrude;Shelly Heimfeld;Irving L. Weissman.
Science (1988)
Purified hematopoietic stem cells can differentiate into hepatocytes in vivo
Eric Lagasse;Heather Connors;Muhsen Al-Dhalimy;Michael Reitsma.
Nature Medicine (2000)
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
Koichi Akashi;Koichi Akashi;David Traver;Toshihiro Miyamoto;Irving L. Weissman.
Nature (2000)
Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
Motonari Kondo;Irving L. Weissman;Koichi Akashi.
Cell (1997)
A role for Wnt signalling in self-renewal of haematopoietic stem cells
Tannishtha Reya;Andrew W. Duncan;Laurie Ailles;Jos Domen.
Nature (2003)
Wnt proteins are lipid-modified and can act as stem cell growth factors
Karl Willert;Jeffrey D. Brown;Esther Danenberg;Andrew W. Duncan.
Nature (2003)
Stem cells: units of development, units of regeneration, and units in evolution.
Irving L Weissman.
Cell (2000)
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
Stanford University
Stanford University
Kyushu University
Stanford University
Harvard University
Harvard University
The University of Texas Southwestern Medical Center
University of California, San Diego
Stanford University
Stanford University
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: